Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT7 | O95251 | 20/20 | 0.83 |
| ▸ | KAT6A | Q92794 | 20/20 | 0.83 |
| ▸ | KAT6B | Q8WYB5 | 9/20 | 0.82 |
| ▸ | KAT5 | Q92993 | 9/20 | 0.82 |
| ▸ | KAT8 | Q9H7Z6 | 9/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26969628 | 1.00 | KAT7 (0.83) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL30680819 | 1.00 | KAT7 (0.83) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL22817349 | 0.91 | KAT7 (1.00) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL22817406 | 0.90 | KAT7 (1.00) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL24866152 | 0.88 | KAT6A (0.83) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL22802508 | 0.88 | KAT7 (0.83) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL30680835 | 0.88 | KAT7 (0.83) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL31472950 | 0.88 | KAT6A (0.83) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL22817448 | 0.88 | KAT7 (1.00) | KAT7KAT6AKAT6BKAT5KAT8 | |
| SCHEMBL30636992 | 0.88 | KAT7 (1.00) | KAT7KAT6AKAT6BKAT5KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4539937-A1 | KAT6 TARGETING COMPOUNDS WITH UBIQUITIN LIGASE BINDING MOIETY | Prelude Therapeutics Incorporated (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-119836416-A | KAT6 targeting compounds with ubiquitin ligase binding moiety | 普莱鲁德疗法有限公司 | 2025-04-15 | — | — | CN | disclosed |
| WO-2023245150-A9 | KAT6 TARGETING COMPOUNDS WITH UBIQUITIN LIGASE BINDING MOIETY | PRELUDE THERAPEUTICS INCORPORATED (US) | 2025-01-16 | — | — | WO | disclosed |